In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents

被引:99
作者
Hajizadeh, Mohammad Reza [1 ,2 ]
Maleki, Haniyeh [1 ,2 ]
Barani, Mahmood [3 ]
Fahmidehkar, Mohammad Ali [4 ]
Mahmoodi, Mehdi [5 ]
Torkzadeh-Mahani, Masoud [6 ]
机构
[1] Rafsanjan Univ Med Sci, Fac Med, Dept Clin Biochem, Rafsanjan, Iran
[2] Rafsanjan Univ Med Sci, Mol Med Res Ctr, Rafsanjan, Iran
[3] Shahid Bahonar Univ Kerman, Dept Chem, Kerman, Iran
[4] Torbat Heydariyeh Univ Med Sci, Res Ctr Adv Technol Med, Ttorbat Heydariyeh, Iran
[5] Kerman Univ Med Sci, Afzalipoor Fac Med, Dept Clin Biochem, Kerman, Iran
[6] Grad Univ Adv Technol, Inst Sci High Technol & Environm Sci, Dept Biotechnol, Kerman, Iran
关键词
Cancer therapy; D-limonene; Niosome; Solubility; DRUG-DELIVERY; BIODEGRADABLE NANOPARTICLES; ANTITUMOR-ACTIVITY; ORAL DELIVERY; NANOTECHNOLOGY; SYSTEM;
D O I
10.4103/1735-5362.268206
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The low solubility of the plant-extracted agent like D-limonene in cancer therapy is a critical problem. In this study, we prepared D-limonene-loaded niosomes (D-limonene/Nio) for cancer therapy through in vitro cytotoxicity assay of HepG2, MCF-7, and A549 cell lines. The niosomal formulation was prepared by film hydration technique with Span (R) 40: Tween (R) 40: cholesterol (35:35:30 molar ratio) and characterized for vesicle distribution size, morphology, entrapment efficiency (EE%), and in vitro release behaviour. The obtained niosomes showed a nanometric size and spherical morphology with EE% about 87 +/- 1.8%. Remarkably prolonged release of D-limonene from niosomes compared to free D-limonene observed. The loaded formulation showed significantly enhanced cytotoxic activity with all three cancer cell lines (HepG2, Macf-7 and A549) at the concentration of 20 mu M. These results indicated that niosome loaded with phytochemicals can be a promising nano-carrier for cancer therapy applications
引用
收藏
页码:448 / 458
页数:11
相关论文
共 40 条
[1]   Critical parameters dictating efficiency of membrane-mediated drug transfer using nanoparticles [J].
Abbasi, Saed ;
Kajimoto, Kazuaki ;
Harashima, Hideyoshi .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 553 (1-2) :398-407
[2]   New frontiers in nanotechnology for cancer treatment [J].
Alexis, Frank ;
Rhee, June-Wha ;
Richie, Jerome P. ;
Radovic-Moreno, Aleksandar F. ;
Langer, Robert ;
Farokhzad, Omid C. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (01) :74-85
[3]  
[Anonymous], ARTIFICIAL CELLS NAN
[4]  
[Anonymous], INT J MED NANORES
[5]  
[Anonymous], CANC EPIDEMIOLOGY PR
[6]   Global incidence of oesophageal cancer by histological subtype in 2012 [J].
Arnold, Melina ;
Soerjomataram, Isabelle ;
Ferlay, Jacques ;
Forman, David .
GUT, 2015, 64 (03) :381-387
[7]   Influence of a Niosomal Formulation on the Oral Bioavailability of Acyclovir in Rabbits [J].
Attia, Ismail A. ;
El-Gizawy, Sanaa A. ;
Fouda, Medhat A. ;
Donia, Ahmed M. .
AAPS PHARMSCITECH, 2007, 8 (04)
[8]   Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer [J].
Barani, Mahmood ;
Mirzaei, Mohammad ;
Torkzadeh-Mahani, Masoud ;
Nematollahi, Mohammad Hadi .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 26 (01) :11-17
[9]  
Behroozeh Aras, 2018, Asian Pac J Cancer Prev, V19, P645
[10]   Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation [J].
Cui, Fude ;
Shi, Kai ;
Zhang, Liqiang ;
Tao, Anjin ;
Kawashima, Yoshiaki .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) :242-250